Shigehiro Yagishita
@syagishi
Laboratory Head, Div. Molecular Pharmacology, National Cancer Center Research Institute. Prev: Respiratory medicine physician at Juntendo Univ.
ID: 1291773972929863680
07-08-2020 16:31:39
24 Tweet
26 Followers
126 Following
Oxford Nanopore のターゲットシークエンスの解析ワークフローを開発し、33人の遺伝性腫瘍疑いの患者に適用した研究のプリプリントを出しました。このワークフローによりSNV、SV、メチル化、Polygenic Risk Scoreを単一のプラットフォームで検出可能なことを実証しました。medrxiv.org/content/10.110…
We publish a new study. Exploratory analysis to predict pneumonitis during durvalumab consolidation therapy for patients with locally advanced non‐small cell lung cancer from proteomic profiling of circulating extracellular vesicles - Thoracic Cancer - onlinelibrary.wiley.com/doi/full/10.11…
Wonderful to see our two important publications this week! #1: #descSPIM paper is out in Nature Communications, the 1st original paper from #DBSB_Juntendo ! If you are using/try to use #tissue_clearing and #LSFM, don't miss our work nature.com/articles/s4146… Brief summary in the tree ↓↓↓